ACA Insurance Exchanges Launch Amid Coverage Questions

  Workers Trained To Help Ease Transition To Affordable Care Act Insurance Marketplaces By: Joe Raedle Getty Images News Workers Trained To Help Ease Transition To Affordable Care Act Insurance Marketplaces. By: Joe Raedle/Getty Images  
National Journal
Clara Ritger
See more stories about...
Clara Ritger
Sept. 30, 2013, 5 p.m.

Lead­ing up to Tues­day’s open­ing of the Af­ford­able Care Act health in­sur­ance ex­changes, much of the polit­ic­al pun­ditry fo­cused on wheth­er the cus­tom­ers would come.

Now that the ex­changes are open for busi­ness, the next ques­tion is wheth­er un­in­sured Amer­ic­ans will be sat­is­fied with what they find when they get there.

“I don’t think we can sit here today and say for cer­tain wheth­er they will ul­ti­mately have the care they need,” said Ceci Con­nolly, man­aging dir­ect­or of Price­wa­ter­house­Coopers’ Health Re­search In­sti­tute. “In our in­ter­views with pro­viders, it was a big con­cern.”

Price­wa­ter­house­Coopers last month re­leased its find­ings that in or­der to lower premi­ums, in­sur­ance com­pan­ies are lim­it­ing the num­ber of hos­pit­als and phys­i­cians avail­able to con­sumers in ACA ex­change plans.

“In­surers passed over ma­jor med­ic­al cen­ters in Chica­go, In­di­ana, Ken­tucky, Los Angeles, Ten­ness­ee, and else­where in an ef­fort to tamp down hos­pit­al and med­ic­al costs,” the re­port said. “But the use of nar­row net­works may also lead to high­er out-of-pock­et ex­penses, es­pe­cially if a pa­tient has a com­plex med­ic­al prob­lem that’s be­ing treated at a hos­pit­al that has been ex­cluded from their health plan.”

Some­times, however, a nar­row net­work in­cludes a pro­vider such as the Mayo Clin­ic, which of­fers a full range of ser­vices, Con­nolly said.

“Much is go­ing to de­pend on the in­di­vidu­al and what their health status and needs are,” she said.

It is un­clear wheth­er pa­tients will be will­ing to make the trade-off of hav­ing few­er choices for a lower price tag. Gary Co­hen, dir­ect­or of the Cen­ter for Con­sumer In­form­a­tion and In­sur­ance Over­sight at the Cen­ters for Medi­care and Medi­caid Ser­vices, said lim­it­ing op­tions to drive down costs isn’t unique to Obama­care.

“The use of nar­row net­works is something that people have been talk­ing about for a long time as a way to keep health care costs down,” said Co­hen, who is lead­ing the im­ple­ment­a­tion of the ex­changes.

But Chris Jac­obs, seni­or health policy ana­lyst at Her­it­age Found­a­tion — the con­ser­vat­ive think tank as­so­ci­ated with Her­it­age Ac­tion’s cam­paign to de­fund Obama­care — said pa­tients have more to worry about than wheth­er they can keep their doc­tor.

“Are there even enough doc­tors in the net­work?” Jac­obs said. “If they get swarmed with people, are they go­ing to be able to take care of them?”

One of the reas­ons the in­dustry has lim­ited the net­works, Con­nolly said, is in re­sponse to pres­sure to keep prices on the ex­change at­tract­ive.

“This is a very price-sens­it­ive pop­u­la­tion that is lower in in­come,” she said.

Ac­cord­ing to the Price­wa­ter­house­Coopers study, 94 per­cent of in­surers be­lieve premi­um prices will mat­ter most to the people weigh­ing in­sur­ance cov­er­age on an ex­change.

It’s why some in­surers have op­ted out of some mar­ket­places al­to­geth­er.

One-third of health in­surers don’t plan to par­ti­cip­ate in the ex­changes, or haven’t yet de­cided, ac­cord­ing to the PwC study, cit­ing con­cerns about prof­it­ab­il­ity, un­der­stand­ing the be­ha­vi­or of newly eli­gible cus­tom­ers, and an­ti­cip­ated high use of ser­vices among those who enter the ex­changes.

In some mar­kets, this re­luct­ance has res­ul­ted in a loss of com­pet­i­tion. Ac­cord­ing to the Health and Hu­man Ser­vices De­part­ment, 5 per­cent of people — in­clud­ing those in West Vir­gin­ia and New Hamp­shire — will be shop­ping for ex­change plans offered by only one in­sur­ance com­pany.

What We're Following See More »
DRUG OFFENDERS
Obama Grants 111 More Commutations
10 hours ago
THE DETAILS

In a release Tuesday afternoon, the White House announced that President Obama has commuted and/or reduced the sentences of another 111 convicted criminals, mostly convicted of drug possession or trafficking. About 35 were serving life sentences.

BUT HE’S NOT ADVOCATING FOR IT
Grassley Open to Lame Duck Hearings on Garland
12 hours ago
THE LATEST

Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.

Source:
DOWN FROM POST-CONVENTION NUMBERS
Monmouth Has Clinton Up Seven
16 hours ago
THE LATEST

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Source:
DEBATE PREP
Clinton Advisers Talking to Psychologists, Trump Ghostwriter
16 hours ago
THE LATEST

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

EPI-PEN PRICES
House Committee Investigating Mylan
19 hours ago
THE LATEST

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.

Source:
×